EndoSphere, Inc. to Present at the OneMedForum2009 in San Francisco, January 13, 2009

New York, NY, January 11, 2009 --(PR.com)-- EndoSphere, Inc., a privately held medical device company, announced today that it will participate in the OneMedPlace Finance Forum in San Francisco, CA from January 13-14, 2009. James McKinley, CEO of EndoSphere, will present on Tuesday, January 13th at 8:30 a.m. Pacific Time, at the Sir Francis Drake Hotel at 450 Powell St. Information about the OneMedPlace Finance forum may be found at http://www.onemedplace.com.

EndoSphere is developing a platform of endoscopically implantable devices for the treatment of metabolic diseases, including obesity and type 2 diabetes. EndoSphere's devices boost the natural functions of the duodenum, including control of appetite and regulation of glucose production.

About EndoSphere:
EndoSphere, Inc. is developing and marketing clinical solutions for endoscopically implantable devices for the treatment of metabolic disorders. For additional information on EndoSphere, please visit their website at www.OneMedPlace.com or contact the Company at 650-430-8291.

About OneMedPlace: OneMedPlace is a virtual community of healthcare and life science companies. It has, for the first time, put in place the innovations that will shape the future of health and medicine—emerging companies and technologies seeking capital, distribution, visibility and resources to help finance, build and grow, and investors and strategic partners looking for health and medical innovations to invest in, acquire, license, distribute, purchase or utilize.

###